Our pre-specified analysis of the five endo-lysosomal proteins most likely to show relevant HD-related alterations (Cathepsin D, Cathepsin F, GM2A, LAMP1 and LAMP2) found no discernible differences in concentration between HD mutation carriers and controls. This evidence concerns the gene LAMP2 and Huntington disease.